The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

小児の夜尿と高年齢者の夜間頻尿は広く見られる臨床症状であり、睡眠時の腎臓での尿産生速度と膀胱での貯留容量のバランスの崩れが特徴である。本論文では、マウスの排尿量を自動記録するための新規な方法を使って、膀胱のギャップ結合タンパク質で ...

AstraZeneca has added another indication to its blockbuster immunotherapy Imfinzi (durvalumab), gaining European approval to treat a type of bladder cancer. Imfinzi is now approved to treat adult ...

Most people with bladder cancer begin treatment by having surgery to remove their cancer. If bladder cancer has spread beyond your bladder, you might have chemotherapy first. This can help treat ...

The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...

Insights show patients with non-muscle invasive bladder cancer want to explore new treatment options, yet fewer than one in five say their doctors discuss all available procedures/treatments at most ...

Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis.